Progyny [PGNY] vs Elevance Health [ELV] Detailed Stock Comparison
Progyny
NASDAQ
Loading...
Elevance Health
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Progyny wins in 6 metrics, Elevance Health wins in 12 metrics, with 0 ties. Elevance Health appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Progyny | Elevance Health | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 38.54 | 13.35 | Elevance Health |
| Price-to-Book Ratio | 3.77 | 1.62 | Elevance Health |
| Debt-to-Equity Ratio | 5.56 | 68.84 | Progyny |
| PEG Ratio | 3.47 | -0.61 | Elevance Health |
| EV/EBITDA | 20.78 | 6.88 | Elevance Health |
| Profit Margin (TTM) | 4.28% | 2.83% | Progyny |
| Operating Margin (TTM) | 7.32% | 5.29% | Progyny |
| EBITDA Margin (TTM) | 7.32% | 5.29% | Progyny |
| Return on Equity | 10.94% | 12.42% | Elevance Health |
| Return on Assets (TTM) | 6.57% | 4.65% | Progyny |
| Free Cash Flow (TTM) | $173.70M | $4.55B | Elevance Health |
| Dividend Yield | N/A | 1.32% | N/A |
| 1-Year Return | 6.10% | -43.29% | Progyny |
| Price-to-Sales Ratio (TTM) | 1.57 | 0.37 | Elevance Health |
| Enterprise Value | $1.68B | $65.23B | Elevance Health |
| EV/Revenue Ratio | 1.35 | 0.35 | Elevance Health |
| Gross Profit Margin (TTM) | 23.72% | N/A | N/A |
| Revenue per Share (TTM) | $14 | $829 | Elevance Health |
| Earnings per Share (Diluted) | $0.59 | $23.56 | Elevance Health |
| Beta (Stock Volatility) | 1.33 | 0.59 | Elevance Health |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Progyny vs Elevance Health Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Progyny | 2.53% | 2.57% | 0.83% | 9.16% | -0.30% | 30.46% |
| Elevance Health | -0.13% | 4.80% | 11.99% | -22.62% | -19.61% | -15.37% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Progyny | 6.10% | -44.49% | -19.10% | 45.11% | 45.11% | 45.11% |
| Elevance Health | -43.29% | -35.96% | 11.66% | 120.26% | 508.61% | 326.92% |
Performance & Financial Health Analysis: Progyny vs Elevance Health
| Metric | PGNY | ELV |
|---|---|---|
| Market Information | ||
| Market Cap | $1.96B | $70.84B |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 1,385,600 | 2,044,719 |
| 90 Day Avg. Volume | 1,083,093 | 2,850,000 |
| Last Close | $23.13 | $309.60 |
| 52 Week Range | $13.39 - $26.76 | $273.71 - $567.26 |
| % from 52W High | -13.57% | -45.42% |
| All-Time High | $68.32 (Nov 01, 2021) | $567.26 (Sep 02, 2024) |
| % from All-Time High | -66.14% | -45.42% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.10% | 0.14% |
| Quarterly Earnings Growth | 0.04% | -0.24% |
| Financial Health | ||
| Profit Margin (TTM) | 0.04% | 0.03% |
| Operating Margin (TTM) | 0.07% | 0.05% |
| Return on Equity (TTM) | 0.11% | 0.12% |
| Debt to Equity (MRQ) | 5.56 | 68.84 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $6.04 | $194.46 |
| Cash per Share (MRQ) | $3.55 | $154.51 |
| Operating Cash Flow (TTM) | $202.00M | $6.45B |
| Levered Free Cash Flow (TTM) | $194.61M | $12.05B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 1.32% |
| Last 12-Month Dividend | N/A | $4.97 |
Valuation & Enterprise Metrics Analysis: Progyny vs Elevance Health
| Metric | PGNY | ELV |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 38.54 | 13.35 |
| Forward P/E | 29.92 | 9.00 |
| PEG Ratio | 3.47 | -0.61 |
| Price to Sales (TTM) | 1.57 | 0.37 |
| Price to Book (MRQ) | 3.77 | 1.62 |
| Market Capitalization | ||
| Market Capitalization | $1.96B | $70.84B |
| Enterprise Value | $1.68B | $65.23B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.35 | 0.35 |
| Enterprise to EBITDA | 20.78 | 6.88 |
| Risk & Other Metrics | ||
| Beta | 1.33 | 0.59 |
| Book Value per Share (MRQ) | $6.04 | $194.46 |
Financial Statements Comparison: Progyny vs Elevance Health
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | PGNY | ELV |
|---|---|---|
| Revenue/Sales | $332.87M | $49.78B |
| Cost of Goods Sold | $253.90M | N/A |
| Gross Profit | $78.97M | N/A |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $24.36M | N/A |
| EBITDA | $25.56M | N/A |
| Pre-Tax Income | $27.08M | $2.29B |
| Income Tax | $9.97M | $548.00M |
| Net Income (Profit) | $17.11M | $1.74B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | PGNY | ELV |
|---|---|---|
| Cash & Equivalents | $109.24M | $7.50B |
| Total Current Assets | $567.69M | N/A |
| Total Current Liabilities | $237.13M | N/A |
| Long-Term Debt | $26.00M | $28.11B |
| Total Shareholders Equity | $467.16M | $42.62B |
| Retained Earnings | $159.37M | $34.55B |
| Property, Plant & Equipment | $42.69M | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | PGNY | ELV |
|---|---|---|
| Operating Cash Flow | $27.84M | $-294.00M |
| Capital Expenditures | $-2.84M | $-196.00M |
| Free Cash Flow | $46.97M | $821.00M |
| Debt Repayment | N/A | $-1.37B |
| Common Stock Repurchase | $0 | $-880.00M |
Short Interest & Institutional Ownership Analysis
| Metric | PGNY | ELV |
|---|---|---|
| Shares Short | 7.76M | 2.84M |
| Short Ratio | 7.47 | 0.92 |
| Short % of Float | 0.12% | 0.01% |
| Average Daily Volume (10 Day) | 1,385,600 | 2,044,719 |
| Average Daily Volume (90 Day) | 1,083,093 | 2,850,000 |
| Shares Outstanding | 85.31M | 227.48M |
| Float Shares | 79.61M | 224.67M |
| % Held by Insiders | 0.08% | 0.00% |
| % Held by Institutions | 1.04% | 0.93% |
Dividend Analysis & Yield Comparison: Progyny vs Elevance Health
| Metric | PGNY | ELV |
|---|---|---|
| Last 12-Month Dividend | N/A | $4.97 |
| Last 12-Month Dividend Yield | N/A | 1.32% |
| 3-Year Avg Annual Dividend | N/A | $5.08 |
| 3-Year Avg Dividend Yield | N/A | 0.32% |
| 3-Year Total Dividends | N/A | $15.23 |
| Ex-Dividend Date | N/A | Mar 10, 2025 |